Open Synthesis Network Project 1

Slides:



Advertisements
Similar presentations
Home Alternatives in the Design of Chemical Synthesis Combining process and medicinal chemistryCombining process and medicinal chemistry Designing for.
Advertisements

1. Identify challenges and opportunities using questions that reference the six research for development themes defined in the AAS Program Proposal. This.
جامعة النجاح الوطنية عمل الطالبة :. روند فخري ابو الرب إشراف الدكتور :. فؤاد محمود.
CONFORMATIONAL ANALYSIS Conformer B INTRODUCTION Conformationally constrained analogues of biologically important peptides can be useful mechanistic probes.
Department Author Lead-like Properties, High- throughput Screening and Combinatorial Library Design Andy Davis, Simon Teague, Tudor Oprea, John Steele,
Advanced Higher Chemistry Unit 3 Aromatics. Aromatics Aromatics are hydrocarbons containing the benzene ring (C 6 H 6 ). The systematic name for the family.
1 THOMSON REUTERS INTEGRITY SM INFLUENZA A: A New Challenging Opportunity for Market Impact.
- Question & Answer Process EUN, Brussels, 30 September 2010 Caroline Kearney, Education Research Analyst Knowledge-Building.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Drug Development
L. Scheffler IB Chemistry 3-4. Lincoln H.S.
Combinatorial Chemistry and Library Design
Heterocyclic Compounds
Dionicio Siegel – Accessing, Understanding, and Optimizing Compounds We are interested in: Providing synthetic access to unique compounds with promising.
How to position yourself on the market?. How do companies recruit?
Development of Alternative and Durable High Performance Cathode Supports for PEM Fuel Cells Cost-Effective Corrosion Protection to Lengthen Fuel Cell Life.
Tetrahydroisoquinoline: Oxidative imine formation, nucleophilic addition reactions and asymmetric selectivity James Fuster, Dr. Rina Soni, Professor Martin.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Abstract The reactions of 4-hydroxycoumarin with substituted α-cyanocinnimate esters gives addition products that are entirely in the form of the enol.
MethodsAbstract Methods Results Printed by Novel 8-Heterocyle Substituted Tetracyclines are Potent and Broad Spectrum Antibacterial Agents with Oral Bioavailability.
 A chemical equation is a short, easy way to show a chemical reaction using symbols instead of words.  A reactant is the substance you have at the beginning.
* Each student must produce an individual investigation, which should address a purposeful research question and incorporate a scientific rationale *
BREED: Generating Novel Inhibitors through Hybridization of Known Ligands (A. C. Pierce, G. Rao, and G. W. Bemis) Richard S. L. Stein CS 379a February.
Synthesis of New Scaffolds via Bisalkyne Cyclizations Catalyzed by Triflic Acid Jaime Alvarez Duque, Kyle Strom, John K. Snyder Boston University, Department.
Background. For designing, discovering or developing a therapeutically relevant molecule, potency and selectivity to the target.
G Open Source Malaria Meeting #9 Nov 24 th 2014 Location: Agenda:
APPLICATIONS Microwave heating is able to heat the target compounds without heating the entire furnace or oil bath This saves time and energy. However,
Identification of structurally diverse Growth Hormone Secretagogue (GHS) agonists by virtual screening and structure-activity relationship analysis of.
항바이러스제 Ritonavir 양혜란. Ritonavir 화학명 1,3-Tiazol-5-ylmethyl[3-hydroxy-5-[3-methyl-2-[methyl-[(2-propan-2- yl-1,3-thiazole-4-yl)methyl]carbamoyl]-aminobutanoyl]amino-1,6-
4 – Investigate and describe the compounds formed by bonding elements. 3 – Describe why certain elements bond with others. 2 – Use the periodic table.
DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS
26th April 2016, BioTrinity - London
G Global Health Design Webinar #5 Open Source Malaria Next Steps Tue 24 th May 8am East Coast US, Brazil, 1pm UK, 2pm CET, SAST, 10pm Sydney This webinar.
ISMN- CNR Palermo a Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), Consiglio Nazionale delle Ricerche (CNR), Via U. La Malfa 153, Palermo,
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Synthetic chemicals and natural products Synthetic chemicals are made by the use of chemically reactive reagents. Natural Products are synthesized from.
GENERAL REMARKS Guidelines and suggestions for GSVC pitch decks Goal of the Presentation Illustration of the business in a concise way Visual support for.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
A custom designed sequential workflow
Observed Phase Behavior
SAMPLE Build a Collaborative Sourcing Process
Chapter 4 – Carbon and Molecular Diversity of Life
An Introduction to Medicinal Chemistry 3/e COMBINATORIAL CHEMISTRY
Partial Synthesis of Heliotridane
Reconstruction site Investigation, Planning, Scheduling, Estimating and Design Eng. Fahmi Tarazi.
Biological explanation for OCD
Organic Reactions Topics 10.5, 10.6 & Review
Describing Chemical Reactions
Facility Operating Standards CC of C Project Report
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Organic Chemistry Mrs. Rose Marie Capanema Mansur.
Chemistry of Aromatic Compounds
Towards Hydrocarbon Analogues of the Porphyrins
AQA GCSE Design & Technology Controlled Assessment Marksheet
Christine Gardner, Allan Jones, David Chapman, Helen Jefferis
Organic Chemistry An Introduction.
Quantenna Communications
Donald R. Deardorff, Department of Chemistry, Occidental College
Controlled Synthesis of Single-chain Nanoparticles Under Various Atom Transfer Radical Coupling Conditions Courtney M. Leo, Ashley Hanlon, Elizabeth Bright,
How Chemoproteomics Can Enable Drug Discovery and Development
Change Fashion Workshop
Beyond
CONCLUSIONS AND FUTURE DIRECTIONS
Reasearch in the Greenberg Group Results and Discussion:
SAMBa Writing Sprint for ITT9 Assignment
L26 TOPIC 8. ADDITIONS TO ALKENES AND ALKYNES (Chapter 8 and parts of chapters 7, 10 and 11)
RTA Sep 26, 2018, Teleconference Call
ORGANIC PHARMACEUTICAL CHEMISTRY IV
Some Further Considerations in Combining Single Case and Group Designs
Matthias Brewer, The University of Vermont, Burlington Vermont, 05405
Presentation transcript:

Open Synthesis Network Project 1 Lead series for Visceral Leishmaniasis

Project Background Lead series originating from screening of Pfizer internal collection SCYX0001780041 identified as initial hit: To date, > 1,000 analogues have been made around this series Some of the key exploration has been published (Mowbray et.al. J.Med.Chem 2015 link) Lead candidates have been identified and are undergoing advanced profiling SCYX0001780041 L.donovani IC50: 5.8 µM Open Source Chemistry

Open Source Chemistry Opportunity DNDi have a clear need for back-up molecules within the series DNDi have identified certain chemical avenues that require further exploration These avenues have been broken down into various “work packages” exploring different areas of the scaffold Open Source Chemistry

Open Source Chemistry Opportunity Each Work Package provides concise data set around related molecules (20-30 compounds) Each Work Package provides a list of target molecules that DNDI would like to have synthesized and tested for potency Within each Work Package there is the scope for participants to propose and synthesize their own analogues, alongside the analogues suggested by DNDi New proposed molecules will need to by cleared and confirmed by DNDi beforehand in order to avoid duplication Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Work package A Open Source Chemistry Open alkyl chain ureas Work package A Handful of acyclic alkyl ureas have been made; activity observed but deprioritized DNDi will provide data set of compounds made within this sub-series (approx. 30) Stability in rodent microsomes seems to be an issue / area for improvement. Balance of ClogP is key for keeping potency and achieving metabolic stability Focus of work package: Improve potency and improve rodent microsomal stability via exploration / combination approach: Examples of target compounds: Library scans (suitable for parallel synthesis from common intermediate) For list of DNDi targets, see associated sdf file Open Source Chemistry

Work package A Open Source Chemistry Open alkyl chain ureas Work package A Handful of acyclic alkyl ureas have been made; activity observed but deprioritized DNDi will provide data set of compounds made within this sub-series (approx. 30) Stability in rodent microsomes seems to be an issue / area for improvement. Balance of ClogP is key for keeping potency and achieving metabolic stability Focus of work package: Improve potency and improve rodent microsomal stability via exploration / combination approach: Examples of target compounds: Alkylation and other derivatization around urea (May require some bespoke synthetic investigation) For list of DNDi targets, see associated sdf file Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Work package B Open Source Chemistry Piperazine ureas Work package B Examples of piperazine and homopiperazine ureas have been made (approx. 35 analogues), with activity observed. Data set of existing piperazines and other compounds will be provided Metabolic stability and optimization of potency needs to be addresses DNDI000296578 L.Infantum IC50: 0.45 µM HLM 51 µL/min/mg.pr DNDI0002491055 L.Infantum IC50: 0.732 µM HLM 51 µL/min/mg.pr Examples of target compounds: Further exploration of this sub-series: (Library analoging, approximately 30-40 compounds, relatively straightforward synthesis) For list of DNDi targets, see associated sdf file Open Source Chemistry

Work package B Open Source Chemistry Piperazine ureas Work package B Examples of piperazine and homopiperazine ureas have been made (approx. 35 analogues), with activity observed. Data set of existing piperazines and other compounds will be provided Metabolic stability and optimization of potency needs to be addresses DNDI000296578 L.Infantum IC50: 0.45 µM HLM 51 µL/min/mg.pr DNDI0002491055 L.Infantum IC50: 0.732 µM HLM 51 µL/min/mg.pr Examples of target compounds: Combine with substituted pyrazole & triazole (Straightforward synthesis) For list of DNDi targets, see associated sdf file Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Work package C Open Source Chemistry Cyclized core Work package C Cyclization of the core to give a partially saturated [5.6] system has demonstrated some potential but is relatively unexplored Relevant data set will be provided (4 compounds) Exploration of this chemical sub-series may require development of target-specific chemistry Examples of target compounds: For list of DNDi targets, see associated sdf file Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Functionality scan of pyridine Work package D Replacement of 2-pyridyl on left-hand side (LHS) has been investigated, but not necessarily for more advanced right hand sides (RHS) Relevant data set will be provided (approx. 20 compounds) New chemistry could be developed to allow parallel synthesis; otherwise this requires bespoke synthesis for each analogue (approx. 4 steps) Examples of target compounds: For list of DNDi targets, see associated sdf file Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Work package E Open Source Chemistry ß-Proline analogues Work package E ß-Proline analogues showed some promise but have been deprioritized in favour of pyrrolidine ureas, mainly due to issues of metabolic stability Data set of 15-20 compounds can be provided Ideally suited to synthesis of single building block followed by analoguing through parallel synthesis DNDI0003084291 L.Infantum IC50: 0.60 µM MRC5 CC50 >64 µM PMM CC50 >64 µM Examples of target compounds: Further investigation + other ring variations? For list of DNDi targets, see associated sdf file Open Source Chemistry

Work packages for chemistry investigation Open alkyl chain ureas A Functionality scan of pyridine D ß-Proline analogues E Cyclized core Piperazine ureas Fluorinated pyrazole analogues & other targets C B F Open Source Chemistry

Fluorinated pyrazole analogues & other targets Work package F Substitution of the 4-position of the pyrazole has been shown to be advantageous, however certain analogues have yet to be synthesized: Expected to be Synthetically challenging Examples of target compounds: For list of DNDi targets, see associated sdf file Open Source Chemistry